Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2005
06/02/2005WO2005049790A2 Skn-1 and gsk-3 genes and proteins
06/02/2005WO2005049789A2 Synthetic mammalian retrotransposon gene
06/02/2005WO2005049786A2 Modulation of angiogenesis by bartonella henselae
06/02/2005WO2005049651A2 Cancer diagnosis and therapy
06/02/2005WO2005049650A1 Lactoferrin polypeptide, process for producing the same and inflammation inducing substance
06/02/2005WO2005049649A1 Process for the purification of il-18 binding protein
06/02/2005WO2005049648A2 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
06/02/2005WO2005049647A2 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens
06/02/2005WO2005049646A2 “seedy1” nuceic acids for making plants having changed growth characteristics
06/02/2005WO2005049645A1 Recovery of a heat shock protein
06/02/2005WO2005049644A2 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system
06/02/2005WO2005049642A2 Genome of legionella pneumophila paris and lens strain-diagnostic and epidemiological applications
06/02/2005WO2005049641A2 Surface-located campylobacter jejuni polypeptides
06/02/2005WO2005049640A2 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
06/02/2005WO2005049639A2 Compositions and methods for protein isolation
06/02/2005WO2005049637A2 Methods for the isolation and purification of defensin polypeptides
06/02/2005WO2005049099A2 Fibres embedded in a glassy protein
06/02/2005WO2005049093A1 Use of microparticles for antigen delivery
06/02/2005WO2005049092A1 Ocular tissue modification
06/02/2005WO2005049084A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure
06/02/2005WO2005049075A2 Compositions and methods for the treatment of tumor of hematopoietic origin
06/02/2005WO2005049073A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
06/02/2005WO2005049072A2 Therapeutic cancer vaccine with fragments of trag-3
06/02/2005WO2005049067A1 Isolated complexes of endotoxin and md-2
06/02/2005WO2005048985A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions
06/02/2005WO2005048951A2 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain
06/02/2005WO2005048918A2 Anthrax vaccine
06/02/2005WO2005048914A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
06/02/2005WO2005048913A2 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment
06/02/2005WO2005048693A2 Plant with improved drought tolerance
06/02/2005WO2005033265A9 Optimized multi-epitope constructs and uses thereof
06/02/2005WO2005030241A3 Treating inflammation using a biological agent that causes cells to release cytokine receptors
06/02/2005WO2005025497A3 Hpv cd8+ t-cell epitopes
06/02/2005WO2005023856A3 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
06/02/2005WO2005023852A3 Epilancin 15x lantibiotic
06/02/2005WO2005018575A3 Estrogen receptor modulators and uses thereof
06/02/2005WO2005018413A3 Methods, kits and antibodies for detecting parathyroid hormone
06/02/2005WO2005017115A3 Cord blood-derived hematopoietic progenitor cells
06/02/2005WO2005014836A3 Chimaeric vector system
06/02/2005WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease
06/02/2005WO2005010027A3 Novel peptidic conjugates for alopecia preventive and curative treatment
06/02/2005WO2005005637A3 Herpes simplex virus comprising a genetically modified glycoprotein d
06/02/2005WO2005001099A8 Protein expression system
06/02/2005WO2005000192A3 Glycogen synthase kinase-3 inhibitors
06/02/2005WO2004112832A3 Immunogenic compositions comprising multiple gonococcal antigens
06/02/2005WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases
06/02/2005WO2004110470A3 Use of collagen peptides to inhibit infection
06/02/2005WO2004110384A3 Hiv-1 envelope glycoproteins having unusual disulfide structure
06/02/2005WO2004104577A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4)
06/02/2005WO2004104023A3 Metal chelate complexes immobilized on solid supports for peptide preparation
06/02/2005WO2004103273A8 Inverse agonist and agonist peptides that stimulate/inhibit hair growth
06/02/2005WO2004101741A3 Transgenic plants with increased glycine-betaine
06/02/2005WO2004099781A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1)
06/02/2005WO2004096136A3 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
06/02/2005WO2004092384A3 Means and methods for diagnosing and treating affective disorders
06/02/2005WO2004087058A3 Targeted mhc class i alpha3 vaccine delivery systems
06/02/2005WO2004083393A3 Enhanced protein thermostability and temperature resistance
06/02/2005WO2004081187A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
06/02/2005WO2004078098A3 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
06/02/2005WO2004076633A3 Hypoxia inducible vegf plasmid for ischemic disease
06/02/2005WO2004074507A8 Method to confer cell culture replication activity to different hepatitis c virus isolates
06/02/2005WO2004074320A3 Therapeutic targets in cancer
06/02/2005WO2004072242A3 Screening of compounds for hematological disorder treatment
06/02/2005WO2004071414A3 Therapeutic anti-hcv (al9) compounds
06/02/2005WO2004069163A3 Cross-protective epitopes of moraxella catarrhalis and use thereof
06/02/2005WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
06/02/2005WO2004060310A8 Human growth hormone crystals and methods for preparing them
06/02/2005WO2004055168A3 Il-21 production in prokaryotic hosts
06/02/2005WO2004050860A3 Compositions, splice variants and methods relating to colon specific genes and proteins
06/02/2005WO2004050853A3 Uses of the snorf55 receptor
06/02/2005WO2004048521A3 Composition and method for treating lupus nephritis
06/02/2005WO2004032614A3 Animal with modification of cytoplasmic dynein heavy chain 1 gene
06/02/2005WO2004031358A3 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof
06/02/2005WO2004030619A3 Protein s protects the nervous system from injury
06/02/2005WO2004027034A3 Methods for assessing the ability of hiv patients to restrict hiv replication
06/02/2005WO2004024894A3 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of il-19 binding
06/02/2005WO2004022576A3 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction
06/02/2005WO2004013347A8 Methods of identifying compounds that modulate protein activity
06/02/2005WO2004007689A3 Regulatory protein for nox enzymes
06/02/2005WO2003090514A3 Adipocyte complement related protein zacrp14
06/02/2005WO2003087375A8 Cartilage differentiation regulating gene
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005WO2003059281A3 Novel variants of rankl protein
06/02/2005WO2003057821A3 Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
06/02/2005US20050120417 Expression cassette with promoter operably linked to polynucleotide or complement encoding polypeptide comprising a basic helix-loop-helix domain, and complements an Arabidopsis ind1mutant phenotype; genetic engineering
06/02/2005US20050120416 Using vector transformation to generate corn seeds homozygous for transgene which conferring artificial nuclear male sterility (AMS) and heterozygous for a fertility-restoring gene linked to a "small seed" phenotype; for use as tool in propagating recombinant plants of preferential phenotypes; bioreactor
06/02/2005US20050120410 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof
06/02/2005US20050120409 Expression vector comprising nucleotide sequences coding hypersensitive response eliciting protein for use in generating disease, insect, drought and heat resistant plants; biological pest control
06/02/2005US20050120408 Propagation of disease/herbicide/stress resistant plants; biological pest control
06/02/2005US20050120398 Animal model for HCV infection
06/02/2005US20050120397 Preventing spermatid differentiation via inhibition of caspase expression; gene expression inhibition; biological pest control; contraceptives; infertility treatment; male contraception
06/02/2005US20050120393 Nucleotide sequences associated with prostate specific gene expression for use as tool in diagnosis, prognosis, classification, prevention and treatment of cell proliferative disorders of urogenital systems
06/02/2005US20050120392 Using animal to identify modulators of blood coagulation; antithrombotic agents; identification and validation of platelet genes as targets for anti-thrombotic or thrombotic compounds
06/02/2005US20050119472 GB virus C and methods of treating viral infections
06/02/2005US20050119471 RNA viral sequences for use in development of vaccine to prevent gastrointestinal disorders in infants and young children
06/02/2005US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders
06/02/2005US20050119464 Protein
06/02/2005US20050119462 Expression vectors and promoters for heterologous gene expression
06/02/2005US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases
06/02/2005US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders